Looking for information on Immutep and its Lag-3 technology?

Get in touch!

 


Thank you for your interest in Immutep and the cancer and autoimmune treatments made possible by our Lag-3 technology. For media requests, or to contact the Immutep team regarding partnerships, email enquiries@immutep.com and a member of our support team will direct your inquiry.

Please add 2 and 5.

* Required

USA Investor Relations

Garth Russell
LifeSci Advisors
Ph: +1 (646) 876-3613

 

Australian Investor Relations

Catherine Strong
Citadel-Magnus
Ph: +61 (0) 406 759 268

Immutep Limited
Sydney Office

Ph: +61 2 8315 7003
Fax: +61 2 8569 1880

Level 12, 95 Pitt Street,
SYDNEY NSW
AUSTRALIA 2000

Immutep S.A.S.
Paris Office

Ph: +33 146835822

Parc Club Orsay
2, rue Jean Rostand
91893 Orsay
France

Immutep GmbH
Leipzig Office

Ph: +49 341 23100372

Deutscher Platz 5a
04103 Leipzig
Germany

Immutep GmbH
Berlin Branch Office

Ph: + 49 30 88716843

Glinkastr. 28
10117 Berlin
Germany

E-Mail List

You may automatically receive Electronic Communications by e-mail, please sign up here.

Shareholder Services
Boardroom

The share registry may be accessed by clicking here.

Ph: +61 2 9290 9600
Fax: +61 2 9279 0664

www.boardroomlimited.com.au

Share Registry
Grosvenor Place, Level 12, 225 George Street
Sydney NSW 2000

Postal Address:
GPO Box 3993
Sydney NSW 2001